Obatoclax (GX 15-070), a pan-BCL-2 family inhibitor, is capable of inducing apoptosis in cancer cells and reactivating HIV-1; however, we found that its effectiveness on latently infected cells varies depending on the methods employed [38]. This evidence concerns the gene BCL2 and cancer.